Charles Garten, MD
Sports Medicine · Atlanta, GANPI 1942234281
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $15,710 of the $15,996 with a category attached, or 98.2%. DJO, LLC accounts for 98.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $3,746 and has fallen 61.3% since, to $1,449 in 2025.
Across 32 payments — averaging $499.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- DJO, LLC$16K
- Theragen, Inc.$145
- Tenex Health Inc.$58
- Bioventus LLC$58
- Amgen$24
Across 16 payments — averaging $7574.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotissue Holdings Inc.$121K
What the payments were for
- Royalty or licence$15,71098%
- Food & beverage$2852%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| DJO, LLC | 27 | $15,710 |
| Theragen, Inc. | 1 | $145 |
| Tenex Health Inc. | 1 | $58 |
| Bioventus LLC | 2 | $58 |
| Amgen | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCARE$3,925
- DONJOY$2,832
- PROCARE Bracing & Supports$2,558
- AIRCAST Bracing & Supports$2,558
- Kneehab XP$145
How this compares
$15,996 in reported general payments places this provider in the 80th percentile of 168 sports medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 22 | $3,796 |
| Celecoxib | 97 | $3,681 |
| Meloxicam | 23 | $154 |
| Zolpidem Tartrate | 12 | $75 |
| Methylprednisolone | 13 | $43 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Atlanta
- John XerogeanesAtlanta$4M
- Spero KarasAtlanta$137K
- Xavier DuraldeAtlanta$77K
- Thomas MyersAtlanta$72K
- Phillip LangerAtlanta$33K
- Richard DanilkowiczAtlanta$32K
- Austin LooneyAtlanta$29K
- James KercherAtlanta$24K
- Kyle HammondAtlanta$18K
- John KoprivaAtlanta$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.